ALK-Abelló A/S (OTC:AKBLF – Get Free Report)’s share price fell 4% on Friday . The company traded as low as $17.90 and last traded at $17.90. 19 shares changed hands during trading, a decline of 98% from the average session volume of 784 shares. The stock had previously closed at $18.65.
ALK-Abelló A/S Stock Performance
The stock’s 50-day moving average price is $18.33 and its two-hundred day moving average price is $14.24.
ALK-Abelló A/S Company Profile
ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. Its product portfolio includes GRAZAX/GRASTEK, RAGWITEK/RAGWIZAX, ACARIZAX/ODACTRA, MITICURE, CEDARCURE, and ITULAZAX/ITULATEK for treatment of allergic rhinitis and allergic asthma. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for the treatment of various allergies, including grass, ragweed, house dust mite, Japanese cedar, tree, and food.
Further Reading
- Five stocks we like better than ALK-Abelló A/S
- What are earnings reports?
- Comprehensive Analysis of PayPal Stock
- What is the Nikkei 225 index?
- Intuitive Surgical Stock Can Trend Much Higher This Year
- Basic Materials Stocks Investing
- Alibaba Stock Analysis: Insights, Trends, and Future Predictions
Receive News & Ratings for ALK-Abelló A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ALK-Abelló A/S and related companies with MarketBeat.com's FREE daily email newsletter.
